Young adults who had COVID-19—even those who never had strong symptoms—may go on to have significant cardiovascular issues later in life.

The singer's family originally filed the lawsuit in November 2018.

The study’s authors developed and validated a new performance measure for TAVR care using data from more than 52,000 patients. They shared their full analysis ahead of print in Circulation.

Certain patients face a "significantly greater risk of AFib" if they take fish oil supplements, the study's authors reported. 

The USPSTF said there is not enough evidence to recommend for or against taking supplements to prevent CVD or cancer. The two exceptions are vitamin E and beta-carotene, which the group warned should not be taken for that purpose. 

When patients with post-TAVR infective endocarditis have a stroke, their risk of in-hospital mortality and all-cause mortality after one year both skyrocket. 

The full analysis will be presented May 17 at ACC.21. 

The TAP-CHF trial is expected to enroll up to 100 AFib patients with a history of HFpEF. 

The Indiana Court of Appeals recently sided with Lake Imaging, agreeing that the Medical Malpractice Act and its statute of limitations also apply to provider relationships.